Spots Global Cancer Trial Database for kidney diseases
Every month we try and update this database with for kidney diseases cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours. | NCT01398306 | Carcinoma Carcinoma, Rena... Neuroendocrine ... Carcinoid Tumor Pancreatic Isle... | Blood sampling ... | 18 Years - | University Medical Center Groningen | |
| A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma | NCT02386111 | Carcinoma, Rena... Kidney Diseases Kidney Neoplasm... Urogenital Neop... Urologic Diseas... Urologic Neopla... Neoplasms Neoplasms by Hi... Clear-cell Meta... | Combination of ... | 18 Years - | Celldex Therapeutics | |
| SUTENT® In The First Line Treatment Of Renal Cell Carcinoma | NCT00460798 | Renal Cell Carc... | Sutent: observa... | - | Pfizer | |
| Renal Cell Carcinoma Microenvironment Discovery Project | NCT04005183 | Renal Cell Carc... | 18 Years - | University Health Network, Toronto | ||
| Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma | NCT01339975 | Carcinoma Carcinoma Renal... Kidney Neoplasm... Kidney Diseases Chemokines | Biological samp... Biological samp... | 18 Years - | University Hospital, Bordeaux | |
| Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days | NCT02547805 | Secondary Hyper... Nephrolithiasis Hyperoxaluria Kidney Stones Dietary Hyperox... | ALLN-177 Placebo | 18 Years - | Allena Pharmaceuticals | |
| Savolitinib vs. Sunitinib in MET-driven PRCC. | NCT03091192 | Carcinoma Carcinoma, Rena... Kidney Neoplasm... Urologic Neopla... Kidney Diseases Neoplasms by Si... Enzyme Inhibito... Protein Kinase ... | Savolitinib Sunitinib | 18 Years - 130 Years | AstraZeneca | |
| Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002 | NCT02282813 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 Capsule... Calcitriol Doxercalciferol Paricalcitol | 18 Years - | OPKO Health, Inc. | |
| A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria | NCT03095885 | Secondary Hyper... Nephrolithiasis Hyperoxaluria Kidney Stones | Test Meal | 18 Years - | Allena Pharmaceuticals | |
| Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial Nephrectomy | NCT05887245 | Renal Cell Carc... Kidney Neoplasm Urologic Neopla... Urogenital Neop... Kidney Diseases | 18 Years - | Centre of Postgraduate Medical Education | ||
| Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives | NCT05635266 | Age-Related Mac... Allergies Alpha-Gal Syndr... Alzheimer Disea... Amyloidosis Ankylosing Spon... Arthritis Alopecia Areata Asthma Atopic Dermatit... Autism Autoimmune Hepa... Behcet's Diseas... Beta-Thalassemi... Cancer Celiac Disease Kidney Diseases COPD Crohn Disease Cystic Fibrosis Diabetes Dravet Syndrome DMD Fibromyalgia Graves Disease Thyroid Disease... Hepatitis Hidradenitis Su... ITP Leukemia ALS Lupus or SLE Lymphoma Multiple Sclero... Myasthenia Grav... Heart Diseases Parkinson Disea... Pemphigus Vulga... Cirrhosis Psoriasis Schizophrenia Scleroderma Sickle Cell Dis... Stroke Ulcerative Coli... Vasculitis Vitiligo | Specimen sample | 18 Years - 85 Years | Sanguine Biosciences | |
| Archival of Human Biological Samples in CU-Med Biobank | NCT04706481 | Healthy Cancer Heart Diseases Neurological Di... Kidney Diseases Diabetes Other Disease | Specimen Collec... | - | Chinese University of Hong Kong | |
| Percutaneous Nephroscopic Treatment of Parapelvic Cysts | NCT05504512 | Kidney Stone Parapelvic Cyst Kidney Diseases Recurrence | No intervention | 18 Years - 70 Years | Xiangya Hospital of Central South University | |
| Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT) | NCT01219855 | Chronic Kidney ... Secondary Hyper... Vitamin D Insuf... | Cohort 1 CTAP10... Cohort 1 CTAP10... Cohort 1 Matchi... Cohort 2 CTAP10... Cohort 2 Matchi... | 18 Years - 85 Years | OPKO Health, Inc. | |
| Description of the Cystatin C as an Early Nephrotoxic Bio-marker in Pediatric Oncology | NCT02822404 | Kidney Diseases | Urinary and blo... | - 18 Years | University Hospital, Toulouse | |
| Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy | NCT02765594 | Primary IgA Nep... | Hydroxychloroqu... Valsartan | 18 Years - 60 Years | Peking Union Medical College Hospital | |
| Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency | NCT01704079 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 30 μg c... Sugar pill to C... | 18 Years - | OPKO Health, Inc. | |
| Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002 | NCT02282813 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 Capsule... Calcitriol Doxercalciferol Paricalcitol | 18 Years - | OPKO Health, Inc. | |
| Renal Hypothermia During Partial Nephrectomy | NCT01529658 | Renal Impairmen... Kidney Diseases Urologic Diseas... Cancer Hypothermia Kidney Cancer | Renal hypotherm... | 18 Years - | Ottawa Hospital Research Institute | |
| Description of the Cystatin C as an Early Nephrotoxic Bio-marker in Pediatric Oncology | NCT02822404 | Kidney Diseases | Urinary and blo... | - 18 Years | University Hospital, Toulouse | |
| Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency | NCT01651000 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 30 μg c... Sugar pill to C... | 18 Years - | OPKO Health, Inc. | |
| Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma | NCT01339975 | Carcinoma Carcinoma Renal... Kidney Neoplasm... Kidney Diseases Chemokines | Biological samp... Biological samp... | 18 Years - | University Hospital, Bordeaux | |
| Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours. | NCT01398306 | Carcinoma Carcinoma, Rena... Neuroendocrine ... Carcinoid Tumor Pancreatic Isle... | Blood sampling ... | 18 Years - | University Medical Center Groningen | |
| Description of the Cystatin C as an Early Nephrotoxic Bio-marker in Pediatric Oncology | NCT02822404 | Kidney Diseases | Urinary and blo... | - 18 Years | University Hospital, Toulouse | |
| Functional Exercise and Nutrition Education Program for Older Adults | NCT04037436 | Chronic Disease Frail Diabetes Mellit... Cancer Chronic Lung Di... Cardiovascular ... Congestive Hear... Hypertension Osteoporosis, O... Arthritis Stroke Kidney Diseases | Strength and Ba... Usual Care | 60 Years - | University of Waterloo | |
| A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma | NCT02386111 | Carcinoma, Rena... Kidney Diseases Kidney Neoplasm... Urogenital Neop... Urologic Diseas... Urologic Neopla... Neoplasms Neoplasms by Hi... Clear-cell Meta... | Combination of ... | 18 Years - | Celldex Therapeutics | |
| Latest Imaging SPECT System Evaluation Phase 1 | NCT04704349 | Rheumatic Disea... Neoplasms Parathyroid Dis... Pulmonary Embol... Heart Diseases Thyroid Disease... Kidney Diseases Dementia Parkinsonian Di... | Scintigraphy | 18 Years - | Centre Hospitalier Régional d'Orléans | |
| MoveStrong at Home: A Feasibility Study of a Model for Remote Delivery of Functional Strength and Balance Training Combined With Nutrition Education for Older Pre-frail Adults. | NCT04663685 | Arthritis Cancer Cardiovascular ... Chronic Lung Di... Congestive Hear... Diabetes Hypertension Kidney Diseases Obesity Osteoporosis Stroke Frailty | Exercise progra... Nutrition educa... | 60 Years - | University of Waterloo | |
| Clinical Validation of a Dried Blood Spot Method for Analysis of Immunosuppressives and Antifungals in Pediatrics | NCT02329808 | Hematologic Dis... Oncology Proble... Kidney Diseases Transplantation... | blood drawing | 2 Years - 18 Years | Radboud University Medical Center | |
| Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy | NCT00526331 | Esophageal Dise... Gastrointestina... Disorder of the... Gynecologic Dis... Kidney Diseases Liver Diseases Pancreatic Dise... Prostate Cancer Spinal Disease | Vigileo Monitor FloTrac Sensor | 18 Years - | M.D. Anderson Cancer Center | |
| Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT) | NCT01219855 | Chronic Kidney ... Secondary Hyper... Vitamin D Insuf... | Cohort 1 CTAP10... Cohort 1 CTAP10... Cohort 1 Matchi... Cohort 2 CTAP10... Cohort 2 Matchi... | 18 Years - 85 Years | OPKO Health, Inc. | |
| Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT) | NCT00792857 | Chronic Kidney ... Secondary Hyper... Chronic Renal I... Chronic Renal F... | CTAP201 Injecti... Doxercalciferol | 18 Years - 80 Years | OPKO Health, Inc. | |
| Latest Imaging SPECT System Evaluation Phase 1 | NCT04704349 | Rheumatic Disea... Neoplasms Parathyroid Dis... Pulmonary Embol... Heart Diseases Thyroid Disease... Kidney Diseases Dementia Parkinsonian Di... | Scintigraphy | 18 Years - | Centre Hospitalier Régional d'Orléans | |
| SUTENT® In The First Line Treatment Of Renal Cell Carcinoma | NCT00460798 | Renal Cell Carc... | Sutent: observa... | - | Pfizer | |
| Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2) | NCT00886353 | Pulmonary Disea... Cardiovascular ... Kidney Diseases Cancer Diseases | APN01 Placebo | 18 Years - | Apeiron Biologics | |
| Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) | NCT05935748 | ccRCC Clear Cell Rena... Kidney Cancer Kidney Neoplasm... Renal Cancer Renal Neoplasms Recurrent Renal... Metastatic Rena... Refractory Rena... Advanced Renal ... Carcinoma Neoplasms Carcinoma, Rena... Neoplasms, Glan... Neoplasm by His... Adenocarcinoma Urologic Neopla... Urogenital Neop... Neoplasms by Si... Kidney Diseases Urologic Diseas... | NKT2152 palbociclib sasanlimab | 18 Years - | NiKang Therapeutics, Inc. | |
| A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment | NCT02301117 | Advanced Solid ... | TAS-102 | 18 Years - | Taiho Oncology, Inc. | |
| Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma | NCT04300140 | Clear Cell Rena... | Batiraxcept Cabozantinib (C... Nivolumab | 18 Years - | Aravive, Inc. | |
| Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma | NCT01339975 | Carcinoma Carcinoma Renal... Kidney Neoplasm... Kidney Diseases Chemokines | Biological samp... Biological samp... | 18 Years - | University Hospital, Bordeaux | |
| Archival of Human Biological Samples in CU-Med Biobank | NCT04706481 | Healthy Cancer Heart Diseases Neurological Di... Kidney Diseases Diabetes Other Disease | Specimen Collec... | - | Chinese University of Hong Kong | |
| Electronic Medical Records and Genomics (eMERGE) Phase III | NCT03394859 | Cardiac Disease Cancer Hypercholestero... Diabetes Kidney Diseases Neuromuscular D... | 1 Day - 120 Years | Vanderbilt University Medical Center | ||
| Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma | NCT04300140 | Clear Cell Rena... | Batiraxcept Cabozantinib (C... Nivolumab | 18 Years - | Aravive, Inc. | |
| Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell Carcinoma | NCT01441661 | Renal Cell Carc... | - | Cancer Foundation, China | ||
| A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) | NCT00753415 | Non-Small Cell ... Breast Cancer Melanoma Upper GI Tract ... Colon Carcinoma Renal Cell Carc... Bladder Carcino... Prostate Cancer | V935 V934-EP | 18 Years - | Merck Sharp & Dohme LLC | |
| Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure | NCT00062621 | Kidney Failure,... Multiple Myelom... | Combined bone m... | 18 Years - 65 Years | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Renal Hypothermia During Partial Nephrectomy | NCT01529658 | Renal Impairmen... Kidney Diseases Urologic Diseas... Cancer Hypothermia Kidney Cancer | Renal hypotherm... | 18 Years - | Ottawa Hospital Research Institute | |
| A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer | NCT02543645 | Carcinoma, Rena... Kidney Diseases Kidney Neoplasm... Urogenital Neop... Urologic Diseas... Urologic Neopla... Neoplasms by Hi... Neoplasms Clear-cell Meta... Melanoma Triple Negative... Bladder Cancer Head and Neck C... Non-small Cell ... | Combination of ... | 18 Years - | Celldex Therapeutics | |
| Patient Reported Unmet Needs for Function and Supportive Occupational- and Physiotherapy Rehabilitation Interventions | NCT04066153 | Cancer Kidney Diseases Heart Failure Neurologic Diso... Liver Diseases Pulmonary Disea... Side Effect Quality of Life Physical Disord... | 18 Years - | Rigshospitalet, Denmark | ||
| Neoadjuvant Immune-based Combinations in Patients Undergoing Nephrectomy for Locally Advanced ccRCC | NCT06114940 | Neoplasms Kidney Neoplasm... Urologic Neopla... Urogenital Neop... Female Urogenit... Urogenital Dise... Kidney Diseases Urologic Diseas... Male Urogenital... Carcinoma Carcinoma, Rena... Antineoplastic ... Immune Checkpoi... | Toripalimab Lenvatinib | 18 Years - | Jinling Hospital, China | |
| Functional Exercise and Nutrition Education Program for Older Adults | NCT04037436 | Chronic Disease Frail Diabetes Mellit... Cancer Chronic Lung Di... Cardiovascular ... Congestive Hear... Hypertension Osteoporosis, O... Arthritis Stroke Kidney Diseases | Strength and Ba... Usual Care | 60 Years - | University of Waterloo | |
| Neoadjuvant Immune-based Combinations in Patients Undergoing Nephrectomy for Locally Advanced ccRCC | NCT06114940 | Neoplasms Kidney Neoplasm... Urologic Neopla... Urogenital Neop... Female Urogenit... Urogenital Dise... Kidney Diseases Urologic Diseas... Male Urogenital... Carcinoma Carcinoma, Rena... Antineoplastic ... Immune Checkpoi... | Toripalimab Lenvatinib | 18 Years - | Jinling Hospital, China | |
| Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis | NCT00035334 | Secondary (AA) ... Rheumatoid Arth... Nephrotic Syndr... Familial Medite... Kidney Diseases Gastrointestina... | NC-503 (Anti-am... | 18 Years - | Bellus Health Inc. - a GSK company | |
| Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors | NCT00001668 | Deafness Kidney Diseases Kidney Neoplasm... Neoplasms Retinal Disease... | - | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
